Jon K. Snodgres
Net Worth

Last updated:

What is Jon K. Snodgres net worth?

The estimated net worth of Mr. Jon K. Snodgres is at least $15,275,427 as of 16 Feb 2023. He owns shares worth $3,621,638 as insider, has earned $6,103,469 from insider trading and has received compensation worth at least $5,550,320 in Repligen Corporation.

What is the salary of Jon K. Snodgres?

Mr. Jon K. Snodgres salary is $693,790 per year as Chief Financial Officer in Repligen Corporation.

How old is Jon K. Snodgres?

Mr. Jon K. Snodgres is 59 years old, born in 1966.

What stocks does Jon K. Snodgres currently own?

As insider, Mr. Jon K. Snodgres owns shares in one company:

Company Title Shares Price per share Total value
Repligen Corporation (RGEN) Chief Financial Officer 29,325 $123.5 $3,621,638

What does Repligen Corporation do?

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

RGEN logo
RGEN
Repligen Corporation
$123.5

Jon K. Snodgres insider trading

Repligen Corporation

Mr. Jon K. Snodgres has made 22 insider trades between 2017-2023, according to the Form 4 filled with the SEC. Most recently he sold 5,647 units of RGEN stock worth $1,129,400 on 16 Feb 2023.

The largest trade he's ever made was exercising 31,753 units of RGEN stock on 26 Nov 2018. As of 16 Feb 2023 he still owns at least 29,325 units of RGEN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,647 $200 $1,129,400
Option
Stock Option (Right to Buy) 466 $59.52 $27,736
Option
Common Stock 466 $59.52 $27,736
Option
Common Stock 3,047 $86.1 $262,347
Option
Stock Option (Right to Buy) 970 $215.58 $209,113
Sale
Common Stock 2,400 $253.16 $607,584
Option
Stock Option (Right to Buy) 3,047 $86.1 $262,347
Option
Common Stock 970 $215.58 $209,113
Sale
Common Stock 4,298 $252.7 $1,086,105
Sale
Common Stock 2,000 $220 $440,000
Option
Stock Option (Right to Buy) 4,166 $46.7 $194,531
Option
Common Stock 4,166 $46.7 $194,531
Sale
Common Stock 470 $172.6 $81,122
Sale
Common Stock 3,545 $110.79 $392,761
Sale
Common Stock 3,545 $192.45 $682,249
Option
Stock Option (Right to Buy) 4,000 N/A N/A
Option
Common Stock 4,000 N/A N/A
Sale
Common Stock 3,957 $82.72 $327,307
Sale
Common Stock 3,957 $192.4 $761,343
Sale
Common Stock 3,086 $193 $595,598
Option
Stock Option (Right to Buy) 3,086 $193 $595,598
Option
Common Stock 3,086 $193 $595,598
Option
Stock Option (Right to Buy) 1,893 N/A N/A
Option
Common Stock 1,893 $59.52 $112,671
Sale
Common Stock 705 N/A N/A
Sale
Common Stock 660 N/A N/A
Sale
Common Stock 15,394 N/A N/A
Option
Stock Option (Right to Buy) 12,194 N/A N/A
Option
Stock Option (Right to Buy) 12,194 $29.23 $356,370
Option
Common Stock 12,194 N/A N/A
Option
Common Stock 12,194 $29.23 $356,370
Sale
Common Stock 1,045 N/A N/A
Sale
Common Stock 610 N/A N/A
Sale
Common Stock 1,100 N/A N/A
Option
Stock Option (Right to Buy) 3,957 N/A N/A
Option
Common Stock 3,957 N/A N/A
Sale
Common Stock 6,467 N/A N/A
Sale
Common Stock 2,645 N/A N/A
Sale
Common Stock 1,875 N/A N/A
Option
Stock Option (Right to Buy) 31,753 N/A N/A
Sale
Common Stock 31,753 N/A N/A
Option
Common Stock 31,753 $27.29 $866,476
Option
Common Stock 31,753 N/A N/A
Sale
Common Stock 14,460 N/A N/A
Option
Stock Option (Right to Buy) 4,000 N/A N/A
Option
Common Stock 4,000 N/A N/A
Sale
Common Stock 1,909 N/A N/A

Repligen key executives

Repligen Corporation executives and other stock owners filed with the SEC: